Roy Herbst
Medical Oncology · Houston, TX
CMS Profile ID: 73386 · NPI: 1619060498
Total Disclosed General Payments
$545,879.40
General-payment records
136
CMS Program Year
2025
Most of this (about 73%) was honoraria.
Payments by Type
| Payment Type | Amount |
|---|---|
| Honoraria | $400,000.00 |
| Consulting Fee | $119,618.39 |
| Travel and Lodging | $22,932.28 |
| Food and Beverage | $2,383.73 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $945.00 |
Top Paying Companies
| Manufacturer / GPO | Amount |
|---|---|
| Immunocore Limited | $484,506.94 |
| AstraZeneca Pharmaceuticals LP | $18,454.66 |
| Merck Sharp & Dohme LLC | $15,780.36 |
| E.R. Squibb & Sons, L.L.C. | $12,188.64 |
| Janssen Research & Development, LLC | $6,255.77 |
| Janssen Biotech, Inc. | $4,972.51 |
Top contributing companies shown; smaller payers may be omitted.
These totals are computed from the official CMS Open Payments program-year 2025 general-payment
file. To see the full, authoritative record for this provider — including research payments and
line-item detail — look them up by exact NPI 1619060498 on the
official CMS Open Payments portal.
Verify this record with CMS
- Confirm the provider's exact NPI: 1619060498.
- Select program year 2025 and general payments in the CMS portal.
- Check individual payment records and their nature-of-payment categories.